首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Synthesis of bridged piperazines with sigma receptor affinity.
【24h】

Synthesis of bridged piperazines with sigma receptor affinity.

机译:具有sigma受体亲和力的桥连哌嗪的合成。

获取原文
获取原文并翻译 | 示例
           

摘要

Bridged piperazines 4 were designed as conformationally restricted piperazine sigma receptor ligands. The chiral pool synthesis started from (S)-glutamate, which was transformed in five reaction steps into the piperazinediones 5 bearing a propionic acid ester side chain. A two-step Dieckmann analogous cyclization provided the bicyclic ketones 7 as key intermediates. The alcohols 8 were prepared by LiAlH4 reduction of the ketones 7. NaBH4 reduction, Williamson ether synthesis and LiAlH4 reduction led to the methyl and benzyl ethers 12 and 13. High sigma1 affinity is attained when one large substituent is introduced either at N-8 or O-2. The most potent sigma1 ligand in this series of compounds is the methyl ether 12b with the N-butyl substituent (K(i)=13.2 nM, selectivity sigma2:sigma1 = 16). Moreover, the N-methyl derivatives 13a (sigma2: K(i)=30.4 nM) and 12a (sigma2 preference) represent promising starting points for the development of potent and selective sigma2 ligands.
机译:桥连哌嗪4被设计为构象受限的哌嗪sigma受体配体。手性库合成从(S)-谷氨酸开始,其在五个反应步骤中转变成带有丙酸酯侧链的哌嗪二酮5。两步狄克曼类似物环化提供了双环酮7作为关键中间体。通过酮的LiAlH4还原制备醇8。NaBH4还原,Williamson醚合成和LiAlH4还原导致甲基和苄基醚12和13。当在N-8或N-8处引入一个大取代基时,可获得高σ1亲和力。 O-2。该系列化合物中最有效的sigma1配体是具有N-丁基取代基的甲基醚12b(K(i)= 13.2 nM,选择性sigma2:sigma1 = 16)。此外,N-甲基衍生物13a(sigma2:K(i)= 30.4 nM)和12a(sigma2优选)代表了开发有效和选择性sigma2配体的有希望的起点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号